Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION UTILIZING BORNAVIRUS VECTOR
Document Type and Number:
WIPO Patent Application WO/2023/033050
Kind Code:
A1
Abstract:
Disclosed are: a bornavirus vector capable of binding to a mutant SOD1 protein and carrying a nucleic acid encoding an antibody or antibody fragment, in which the antibody or antibody fragment contains a heavy-chain variable region that may have substitution by 3 or less amino acid residues and comprises a heavy-chain CDR1 comprising the amino acid sequence of GFSLNTSGMG (SEQ ID NO:1), a heavy-chain CDR2 comprising the amino acid sequence of IWWDDDK (SEQ ID NO:2) and a heavy-chain CDR3 comprising the amino acid sequence of ARLGYAMDY (SEQ ID NO:3) and/or a light-chain variable region that may have substitution by 3 or less amino acid residues and comprises a light-chain CDR1 comprising the amino acid sequence of QNVGGTN (SEQ ID NO:4), a light-chain CDR2 comprising the amino acid sequence for SAS and a light-chain CDR3 comprising the amino acid sequence of QQYYIYPYT (SEQ ID NO:5); a recombinant virus which contains RNA encoded in the bornavirus vector; a cell infected by the recombinant virus; and a pharmaceutical composition containing the cell.

Inventors:
TOMONAGA KEIZO (JP)
MAKINO AKIKO (JP)
SAKAI MADOKA (JP)
KOMORIZONO RYO (JP)
URUSHITANI MAKOTO (JP)
MORIMURA TOSHIFUMI (JP)
MINAMIYAMA SUMIO (JP)
Application Number:
PCT/JP2022/032784
Publication Date:
March 09, 2023
Filing Date:
August 31, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV KYOTO (JP)
NATIONAL UNIV CORPORATION SHIGA UNIV OF MEDICAL SCIENCE (JP)
International Classes:
C12N15/86; A61K35/76; A61P21/02; C12N5/10; C12N7/01; C07K16/40; C07K16/46; C12N15/13
Domestic Patent References:
WO2010113647A12010-10-07
WO2010113647A12010-10-07
Foreign References:
JP2009507475A2009-02-26
JP2014504156A2014-02-20
JP2009529498A2009-08-20
JP2018148865A2018-09-27
JP2018148865A2018-09-27
Other References:
SUMIO MINAMIYAMA , MADOKA SAKAI , YUKO YAMAGUCHI , RYOTA HIKIAMI , HIDEKI WADA , MAKIKO HASHI , AKEMI SHODAI , AKIKO MAKINO, TAKAK: "AO-01-1 A single Intrathecal injection of OPC expressing scFv against misfolded SOD1 improved ALS model rats", CLINICAL NEUROLOGY, vol. 61, no. S1, 10 April 2021 (2021-04-10), JP , pages S221, XP009544134, ISSN: 0009-918X, DOI: 10.5692/clinicalneurol.61_supplement_S221
MINAMIYAMA, SUMIO; SAKAI, MADOKA; YAMAGUCHI, YUKO; HIKIAMI, RYOTA; TAMAKI, YOSHITAKA; SHODAI, AKEMI; MAKINO, AKIKO; MAKI, TAKAKUNI: "TST-13 A novel cell transplantation therapy for familial ALS using oligodendrocyte precursor cells expressing scFv specific for misfolded SOD1", AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, vol. 20, no. Suppl. 1, 1 January 2019 (2019-01-01), pages 224 - 225, XP009544538, ISSN: 2167-8421
SUMIO MINAMIYAMA, MADOKA SAKAI, YUKO YAMAGUCHI, RYOTA HIKIAMI, YOSHITAKA TAMAKI, AKEMI SHODAI, AKIKO MAKINO, TAKAKUNI MAKI, KEIZO : "AO-02-4: A novel cell transplantation therapy for ALS using OPCs expressing scFv recognizing misfolded SOD1", 60TH ANNUAL MEETING OF THE JAPANESE SOCIETY OF NEUROLOGY; MAY 22-25, 2019, vol. 59, no. S213, 1 January 2019 (2019-01-01) - 25 May 2019 (2019-05-25), JP, pages 340, XP009544096
PRIYANKA PATEL: "Adeno-associated Virus–mediated Delivery of a Recombinant Single-chain Antibody Against Misfolded Superoxide Dismutase for Treatment of Amyotrophic Lateral Sclerosis", MOLECULAR THERAPY, vol. 22, no. 3, 1 March 2014 (2014-03-01), US , pages 498 - 510, XP055510935, ISSN: 1525-0016, DOI: 10.1038/mt.2013.239
MICROBIOL IMMUNOL, vol. 61, no. 9, September 2017 (2017-09-01), pages 380 - 386
J VIROL., vol. 85, no. 23, December 2011 (2011-12-01), pages 12170 - 8
SCI REP., vol. 6, 18 May 2016 (2016-05-18), pages 26154
FUJINO K ET AL., MICROBIOL IMMUNOL., vol. 61, no. 9, September 2017 (2017-09-01), pages 380 - 386
MIYOSHI, H ET AL.: "Gene delivery to hematopoietic stem cells using lentiviral vectors", METHODS MOL. BIOL., vol. 246, 2004, pages 429 - 38, XP055877454
Attorney, Agent or Firm:
SAEGUSA & PARTNERS (JP)
Download PDF: